Jacques De Jong is an interesting study. Now at Philips (since June 15) as a QA Manager, his last role (minus a short stint (2 months) at Dekra) was with Future DX as a principal scientist/technical architect. Previous to this he was with bioMerieux for 7 years where he was Director of Immunodiagnostics R&D and then Director of Molecular Diagnostics. One could assume he has experience with our technology and is in a position to use it. From his bio:
"I am a medical biologist, with a Ph.D in Immunology. I have considerable experience in the In Vitro Diagnostic industry and have held since 1998 various positions in R&D (Principal Scientist, Project Manager, Department head). I have gained extensive knowledge of GMP, GLP regulations, CE marking and FDA submission"
Jacques De Jong is an interesting study. Now at Philips (since...
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
-0.001(3.67%) |
Mkt cap ! $52.28M | |||
| Open | High | Low | Value | Volume |
| 2.2¢ | 2.3¢ | 2.1¢ | $7.812K | 349.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 828094 | 2.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.2¢ | 1102151 | 4 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| ADO (ASX) Chart |